EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exenatide and Metformin Improve Serum Indices and Intestinal Flora in patients with Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease

Xiaojie Jiang, Tingting Shi, Dan Han, Juan Chen

Journal of the Pakistan Medical Association · 2023

DOI: 10.47391/jpma.8295 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Pakistan Medical Association, 2023. Verfasst von Xiaojie Jiang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Preparation, The Hangzhou Xixi Hospital Affiliated to Zhejiang University School of Medicine, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Metformin, Non-alcoholic Fatty Liver Disease, Gastrointestinal Microbiome. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of the study was to investigate the influence of Exenatide combined with Metformin on fasting blood glucose, postprandial glucose, triglycerides, total cholesterol, alanine aminotransferase, aspartate aminotransferase, and intestinal flora in type 2 diabetes mellitus cases with non-alcoholic fatty liver disease. A total of 128 type 2 diabetes mellitus patients with non-alcoholic fatty liver disease, diagnosed from January 2019 to January 2022, were included and randomly assigned to either Group A (n=64) or Group B (n=64). Group A received Metformin, while Group B received Exenatide injection and Metformin. After 24 weeks of treatment, blood glucose indices (fasting blood glucose and postprandial glucose), blood lipid indices (triglycerides and total cholesterol), liver function indices (alanine aminotransferase and aspartate aminotransferase) were all lower in Group B than in Group A (P < 0.001 for all). ---Continue

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2MetforminNon-alcoholic Fatty Liver DiseaseGastrointestinal MicrobiomeHumansExenatideBlood GlucoseLiverTriglyceridesCholesterolTransaminasesHypoglycemic Agents

Stichwörter der Autor:innen

Type 2 di abetes mel litus ; Non-alcoholic fatty liver disease; Metformin; Exen…

Substanzen

MetforminExenatideBlood GlucoseTriglyceridesCholesterolTransaminasesHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Pharmaceutical Preparation, The Hangzhou Xixi Hospital Affiliated to Zhejiang University School of Medicine, China.
  • Department of Pharmacy, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, China.
  • Department of Endocrine, The Hangzhou Xixi Hospital Affiliated to Zhejiang University School of Medicine, China.

Zitieren

APA

Jiang, X., Shi, T., Han, D., & Chen, J. (2023). Exenatide and Metformin Improve Serum Indices and Intestinal Flora in patients with Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease. Journal of the Pakistan Medical Association. https://doi.org/10.47391/jpma.8295

Vancouver

Jiang X, Shi T, Han D, Chen J. Exenatide and Metformin Improve Serum Indices and Intestinal Flora in patients with Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease. Journal of the Pakistan Medical Association. 2023. doi:10.47391/jpma.8295

BibTeX
@article{Jiang2023,
  author = {Jiang, Xiaojie and Shi, Tingting and Han, Dan and Chen, Juan},
  title = {Exenatide and Metformin Improve Serum Indices and Intestinal Flora in patients with Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease},
  journal = {Journal of the Pakistan Medical Association},
  year = {2023},
  doi = {10.47391/jpma.8295}
}
Kostenlos starten →